medline.ch Onkologie Respirationstrakt

	Prediction of Radiation Pneumonitis With Machine Learning in Stage III Lung Cancer: A Pilot Study. Technol Cancer Res Treat Yakar M, Etiz D, Metintas M, Ak G, Celik O. PMID: 33969761 [PubMed - in process]
	Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment. Mol Oncol Filipska M, Rosell R. PMID: 33969622 [PubMed - as supplied by publisher]
	Survival and pretreatment prognostic factors for extensive-stage small cell lung cancer: A comprehensive analysis of 358 patients. Thorac Cancer Huang LL, Hu XS, Wang Y, Li JL, Wang HY, Liu P, Xu JP, He XH, Hao XZ, Jiang PD, Liu YT, Luo J, Zhou SY, Wang JW, Yang JL, Qin Y, Yuan P, Lin L, Shi YK. PMID: 33969619 [PubMed - as supplied by publisher]
	Circulating tumor cells with epithelial-mesenchymal transition markers as potential biomarkers for the diagnosis of lung cancer. World J Clin Cases Jiang SS, Mao CG, Feng YG, Jiang B, Tao SL, Tan QY, Deng B. PMID: 33969055 [PubMed]
	Application of Artificial Neural Network to Preoperative ¹⁸F-FDG PET/CT for Predicting Pathological Nodal Involvement in Non-small-cell Lung Cancer Patients. Front Med (Lausanne) Taralli S, Scolozzi V, Boldrini L, Lenkowicz J, Pelliccioni A, Lorusso M, Attieh O, Ricciardi S, Carleo F, Cardillo G, Calcagni ML. PMID: 33968968 [PubMed]
	Molecular Pathology of Pulmonary Large Cell Neuroendocrine Carcinoma: Novel Concepts and Treatments. Front Oncol Yoshimura M, Seki K, Bychkov A, Fukuoka J. PMID: 33968782 [PubMed]
	Radiotherapy in the Era of ImmunotherapyÂ With a Focus on Non-Small-Cell Lung Cancer: Time to Revisit Ancient Dogmas? Front Oncol Khalifa J, Mazieres J, Gomez-Roca C, Ayyoub M, Moyal EC. PMID: 33968769 [PubMed]
	Nivolumab and Hypofractionated Radiotherapy in Patients With Advanced Lung Cancer: ABSCOPAL-1 Clinical Trial. Front Oncol Ye H, Pang H, Shi X, Ren P, Huang S, Yu H, Wu J, Lin S. PMID: 33968760 [PubMed]
	Commentary: Overall Survival in Heart Disease-Related Death in Non-Small Cell Lung Cancer Patients: Nonimmunotherapy Versus Immunotherapy Era: Population-Based Study. Front Oncol Jiao Y, Qian C, Fei S. PMID: 33968737 [PubMed]
	Pre-Immunotherapy Contrast-Enhanced CT Texture-Based Classification: A Useful Approach to Non-Small Cell Lung Cancer Immunotherapy Efficacy Prediction. Front Oncol Shen L, Fu H, Tao G, Liu X, Yuan Z, Ye X. PMID: 33968716 [PubMed]
	Circulating Biomarkers for Early Stage Non-Small Cell Lung Carcinoma Detection: Supplementation to Low-Dose Computed Tomography. Front Oncol Kan CFK, Unis GD, Li LZ, Gunn S, Li L, Soyer HP, Stark MS. PMID: 33968710 [PubMed]
	Andrographolide Against Lung Cancer-New Pharmacological Insights Based on High-Throughput Metabolomics Analysis Combined with Network Pharmacology. Front Pharmacol Luo W, Jia L, Zhang JW, Wang DJ, Ren Q, Zhang W. PMID: 33967748 [PubMed]
	Gemcitabine maintenance therapy after gemcitabine and platinum drug chemotherapy for naive stage IIIB/IV squamous cell lung cancer: a phase II study. Anticancer Drugs Hamai K, Fujitaka K, Kitaguchi S, Tamamoto S, Takao S, Nishida A, Furutama J, Horimasu Y, Masuda T, Miyamoto S, Awaya Y, Kondo T, Shoda H, Ishikawa N, Yamasaki M, Hattori N. PMID: 33967202 [PubMed - as supplied by publisher]
	The predictive value of postoperative C-reactive protein (CRP), procalcitonin (PCT) and triggering receptor expressed on myeloid cells 1 (TREM-1) for the early detection of pulmonary infection following laparoscopic general anesthesia for cervical cancer treatment. Ann Palliat Med Liu Y, Tian L, You J, Li Y. PMID: 33966397 [PubMed - in process]
	Molecular biomarker testing for non-small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group. J Pathol Transl Med Chang S, Shim HS, Kim TJ, Choi YL, Kim WS, Shin DH, Kim L, Park HS, Lee GK, Lee CH, Korean Cardiopulmonary Pathology Study Group.. PMID: 33966368 [PubMed - as supplied by publisher]
	Efficacy of atezolizumab to treat non-small-cell lung cancer: a meta-analysis based on randomized clinical trials. Pharmazie Hu C, Liang Z, Lai P, Wang X, Zhao C. PMID: 33964995 [PubMed - in process]
	Predictive value of pretreatment PD-L1 expression in EGFR-mutant non-small cell lung cancer: a meta-analysis. World J Surg Oncol Peng Z, Lin H, Zhou K, Deng S, Mei J. PMID: 33964931 [PubMed - in process]
	Predictors of attrition in a smoking cessation trial conducted in the lung cancer screening setting. Contemp Clin Trials Kim E, Williams RM, Eyestone E, Cordon M, Smith L, Davis K, Luta G, Anderson ED, McKee B, Batlle J, Ramsaier M, Howell J, Parikh V, Geronimo M, Stanton C, Niaura R, Abrams D, Taylor KL, Lung Screening, Tobacco and Health Trial.. PMID: 33964415 [PubMed - as supplied by publisher]
	Immunotherapy as Single Treatment for Non-small-cell Lung Cancer Patients with Brain Metastases: a systematic review and meta-analysis - the META-L-BRAIN study. J Thorac Oncol Loiola de Alencar VT, Camandaroba MPG, Pirolli R, Fogassa CAZ, Cordeiro de Lima VC. PMID: 33964398 [PubMed - as supplied by publisher]
	Completion Pneumonectomy for Second Primary/Primary Lung Cancer and Local Recurrence Lung Cancer. Ann Thorac Surg Miyahara N, Nii K, Benazzo A, Iwasaki A, Klepetko W, Hoetzenecker K. PMID: 33964258 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 114905

Seite 1 von 5746

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung